Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 22C3 pharmDx (Code SK006) assay has received European IVDR ...

Agilent (A) announced its PD-L1 IHC 22C3 pharmDx assay has received European IVDR certification for the use as a Companion Diagnostic to aid in ...

Pinpoint Predictive, an actuarial AI platform for property and casualty insurers, empowers carriers to quantify risk and predict loss ratios earlier and more accurately than traditional ...

Delaware State University's unveiling of its new College of Agriculture Science and Technology building – in partnership with ...

PTC Therapeutics, Inc. announced today that the company will host a webcast conference call to report its first quarter 2025 financial results and provide an update on the company's business and ...

The PD-L1 IHC 22C3 PharmDx (Code SK006) assay is now certified for use to aid treatment decisions for patients with gastric or gastroesophageal junction adenocarcinoma.

Agilent's Sally Frank also said the new building ... providers across the state through its Child Development Associate certification program.

Leerink Partners analyst Puneet Souda maintained a Buy rating on Agilent (A – Research Report) yesterday and set a price target of $125.00. The ...